Report Detail
Global Oxaliplatin Market Growth 2019-2024
- RnM3035417 |
- 27 February, 2019 |
- Global |
- 158 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Teva and Jiangsu Hengrui Medicine.
The technological level of Oxaliplatin in China has a big gap compared with the international advanced level. Outstanding performance in product application performance is not outstanding, function is not strong, supporting enough, clean low level, product updates slow, long development cycle. There is little Oxaliplatin performance in China at or near the international advanced level.
According to this study, over the next five years the Oxaliplatin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oxaliplatin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxaliplatin market by product type, application, key manufacturers and key regions and countries.
This study considers the Oxaliplatin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Mannitol
Glucose Solution
Lactose Solution
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Oxaliplatin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Oxaliplatin market by identifying its various subsegments.
Focuses on the key global Oxaliplatin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oxaliplatin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oxaliplatin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Oxaliplatin Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Oxaliplatin Consumption 2014-2024
- 2.1.2 Oxaliplatin Consumption CAGR by Region
- 2.2 Oxaliplatin Segment by Type
- 2.2.1 Mannitol
- 2.2.2 Glucose Solution
- 2.2.3 Lactose Solution
- 2.2.4 Other
- 2.3 Oxaliplatin Consumption by Type
- 2.3.1 Global Oxaliplatin Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Oxaliplatin Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Oxaliplatin Sale Price by Type (2014-2019)
- 2.4 Oxaliplatin Segment by Application
- 2.4.1 Colorectal Cancer
- 2.4.2 Stomach Cancer
- 2.4.3 Ovarian Cancer
- 2.4.4 Other
- 2.5 Oxaliplatin Consumption by Application
- 2.5.1 Global Oxaliplatin Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Oxaliplatin Value and Market Share by Application (2014-2019)
- 2.5.3 Global Oxaliplatin Sale Price by Application (2014-2019)
3 Global Oxaliplatin by Players
- 3.1 Global Oxaliplatin Sales Market Share by Players
- 3.1.1 Global Oxaliplatin Sales by Players (2017-2019)
- 3.1.2 Global Oxaliplatin Sales Market Share by Players (2017-2019)
- 3.2 Global Oxaliplatin Revenue Market Share by Players
- 3.2.1 Global Oxaliplatin Revenue by Players (2017-2019)
- 3.2.2 Global Oxaliplatin Revenue Market Share by Players (2017-2019)
- 3.3 Global Oxaliplatin Sale Price by Players
- 3.4 Global Oxaliplatin Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Oxaliplatin Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Oxaliplatin Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Oxaliplatin by Regions
- 4.1 Oxaliplatin by Regions
- 4.1.1 Global Oxaliplatin Consumption by Regions
- 4.1.2 Global Oxaliplatin Value by Regions
- 4.2 Americas Oxaliplatin Consumption Growth
- 4.3 APAC Oxaliplatin Consumption Growth
- 4.4 Europe Oxaliplatin Consumption Growth
- 4.5 Middle East & Africa Oxaliplatin Consumption Growth
5 Americas
- 5.1 Americas Oxaliplatin Consumption by Countries
- 5.1.1 Americas Oxaliplatin Consumption by Countries (2014-2019)
- 5.1.2 Americas Oxaliplatin Value by Countries (2014-2019)
- 5.2 Americas Oxaliplatin Consumption by Type
- 5.3 Americas Oxaliplatin Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Oxaliplatin Consumption by Countries
- 6.1.1 APAC Oxaliplatin Consumption by Countries (2014-2019)
- 6.1.2 APAC Oxaliplatin Value by Countries (2014-2019)
- 6.2 APAC Oxaliplatin Consumption by Type
- 6.3 APAC Oxaliplatin Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Oxaliplatin by Countries
- 7.1.1 Europe Oxaliplatin Consumption by Countries (2014-2019)
- 7.1.2 Europe Oxaliplatin Value by Countries (2014-2019)
- 7.2 Europe Oxaliplatin Consumption by Type
- 7.3 Europe Oxaliplatin Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Oxaliplatin by Countries
- 8.1.1 Middle East & Africa Oxaliplatin Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Oxaliplatin Value by Countries (2014-2019)
- 8.2 Middle East & Africa Oxaliplatin Consumption by Type
- 8.3 Middle East & Africa Oxaliplatin Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Oxaliplatin Distributors
- 10.3 Oxaliplatin Customer
11 Global Oxaliplatin Market Forecast
- 11.1 Global Oxaliplatin Consumption Forecast (2019-2024)
- 11.2 Global Oxaliplatin Forecast by Regions
- 11.2.1 Global Oxaliplatin Forecast by Regions (2019-2024)
- 11.2.2 Global Oxaliplatin Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Oxaliplatin Forecast by Type
- 11.8 Global Oxaliplatin Forecast by Application
12 Key Players Analysis
- 12.1 Sanofi-Aventis
- 12.1.1 Company Details
- 12.1.2 Oxaliplatin Product Offered
- 12.1.3 Sanofi-Aventis Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Sanofi-Aventis News
- 12.2 Yakult honsha
- 12.2.1 Company Details
- 12.2.2 Oxaliplatin Product Offered
- 12.2.3 Yakult honsha Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Yakult honsha News
- 12.3 Dr Reddy's laboratories
- 12.3.1 Company Details
- 12.3.2 Oxaliplatin Product Offered
- 12.3.3 Dr Reddy's laboratories Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Dr Reddy's laboratories News
- 12.4 Sun Pharmaceutical
- 12.4.1 Company Details
- 12.4.2 Oxaliplatin Product Offered
- 12.4.3 Sun Pharmaceutical Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sun Pharmaceutical News
- 12.5 Teva
- 12.5.1 Company Details
- 12.5.2 Oxaliplatin Product Offered
- 12.5.3 Teva Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Teva News
- 12.6 Fresenius Kabi
- 12.6.1 Company Details
- 12.6.2 Oxaliplatin Product Offered
- 12.6.3 Fresenius Kabi Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Fresenius Kabi News
- 12.7 Hospira
- 12.7.1 Company Details
- 12.7.2 Oxaliplatin Product Offered
- 12.7.3 Hospira Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Hospira News
- 12.8 Mylan
- 12.8.1 Company Details
- 12.8.2 Oxaliplatin Product Offered
- 12.8.3 Mylan Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Mylan News
- 12.9 Jiangsu Hengrui Medicine
- 12.9.1 Company Details
- 12.9.2 Oxaliplatin Product Offered
- 12.9.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Jiangsu Hengrui Medicine News
- 12.10 Nanjing Pharmaceutical Factory
- 12.10.1 Company Details
- 12.10.2 Oxaliplatin Product Offered
- 12.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Nanjing Pharmaceutical Factory News
- 12.11 Jiangsu Aosaikang Pharmaceutical
- 12.12 Qilu Pharmaceutical
- 12.13 Hisun Pharmaceutical
- 12.14 Lunan Pharmaceutical
- 12.15 Luoxin
- 12.16 Halfsky Pharmacy
- 12.17 YRPG
- 12.18 Hainan Jinrui Pharmaceutical
- 12.19 Jari Pharmaceutical
- 12.20 Chiatai Tianqing
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Oxaliplatin . Industry analysis & Market Report on Oxaliplatin is a syndicated market report, published as Global Oxaliplatin Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Oxaliplatin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
